D-0316

· Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for D-0316, covering 2024-04-09 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC [Phase 2, Phase 3]

See pricing